Business Trip

59 Episodes

1. Holy poop! Mental health and the gut (part 2 with Bloom Science)

   Published: 28/09/2023
2. Holy poop! Mental health and the gut (part 1 with Holobiome)

   Published: 14/09/2023
3. Ketamine for OCD: Carolyn Rodriguez (Stanford pt 3)

   Published: 24/08/2023
4. Are psychedelics effective under anesthesia?: Boris Heifets (Stanford pt 2)

   Published: 17/08/2023
5. The Startup Landscape for Expanding Consciousness

   Published: 09/08/2023
6. Stanford Psychedelic Overview: Robert Malenka (Stanford pt 1)

   Published: 20/07/2023
7. Live from Psychedelic Science 2023

   Published: 07/07/2023
8. What VCs Look for in Psychedelic Companies

   Published: 09/06/2023
9. Developing Non-Hallucinogenic Psychedelics: Bryan Roth

   Published: 15/05/2023
10. Behind the Scenes of PsyMed Ventures

    Published: 14/04/2023
11. The 2023 Psychedelic Industry Landscape with Psychedelic Alpha

    Published: 27/02/2023
12. The State of Psychedelics (Part 2): Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)

    Published: 18/01/2023
13. The quest to improve MDMA

    Published: 20/12/2022
14. Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment

    Published: 29/11/2022
15. Perspectives from Christian Angermayer, investor and founder in psychedelics

    Published: 27/10/2022
16. Soltara: an ethical and profitable ayahuasca retreat

    Published: 14/09/2022
17. Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics

    Published: 16/08/2022
18. Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti

    Published: 10/08/2022
19. Microdosing (part 1): James Fadiman and the fundamentals of microdosing

    Published: 03/08/2022
20. How the DEA and FDA will regulate psychedelic medicine

    Published: 24/06/2022